Latest news

Vumerity® (diroximel fumarate) will be listed under the Pharmaceutical Benefit Scheme (PBS).

Ros Harman has announced her resignation from the MSWA Board after 18 years of service and valued contribution.

MSWA is proud to be funding this important West Australian research, led by Professor Bruni Meloni, that will potentially provide the first effective treatment to minimise the damage that occurs in the early phases of stroke.

The survey, where 1,748 Australians (of which 525 are living with MS) participated, revealed there is a disconnect between expectations and workplace realities for those with a health condition.

Margaret Cable, from Toodyay, was diagnosed with MS in the early days of COVID-19. Her story is a heartening example of “I connect, we connect” – the official tagline of World MS Day 2022.

International Nurses Day is our chance to say thank you and show our appreciation to those who go above and beyond each and every day, our nurses.

Professor Moira Sim from Edith Cowan University talks about the Systematic Profiling in Neurological Conditions (SPIN) research project.

MSWA remains alert as we monitor the COVID-19 situation. This article provides a current updates and useful links for further information.

TONiC aims to identify the factors most affecting quality of life for people with motor neurone disease and Parkinson’s, and how outcomes and services could be improved. The research also explores the role of genetic and environmental factors associated with neurological diseases.

An MSWA funded research project will trial specially made glasses to see the effects of light therapy on fatigue and excessive daytime sleepiness.